Dr Reddy’s Laboratories launches generic version of Nexavar tabs in US market

The tablets, are available in 200 mg tablets in bottle count sizes of 120

Dr Reddy’s Laboratories has announced the launch of Dr Reddy’s Sorafenib Tablets, USP, 200 mg, a therapeutic-generic equivalent of
Nexavar (sorafenib) Tablets in the US market following the approval by the US Food and Drug Administration (US FDA).

“We are pleased to launch this important generic product, illustrating our continued commitment to bring affordable generic medicines to market for patients,” says Marc Kikuchi, CEO, North America Generics, Dr Reddy’s Laboratories.

Dr Reddy’s Sorafenib Tablets, USP, are available in 200 mg tablets in bottle count sizes of 120.